Multimodal ctDNA profiling identifies fragmentomics and tumor fraction as independent prognostic biomarkers of ovarian cancer survival: the MITO-16a/MANGO-OV2a trial experience

The Journal of Liquid Biopsy · Published 2025-11-01 · DOI 10.1016/j.jlb.2025.100336

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.jlb.2025.100336

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2025

Related articles